SYVOLAP, V. V.; VIZIR-TRONOVA, O. V. Influence of additional risk factors on the antihypertensive efficacy of eprosartan and telmisartan in patients with essential hypertension. Pathologia, [S. l.], n. 3, 2017. DOI: 10.14739/2310-1237.2017.3.118311. Disponível em: http://pat.zsmu.edu.ua/article/view/118311. Acesso em: 3 may. 2024.